Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Cell Cycle (Georgetown, Tex.)|November 29, 2012
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3William H Chappell, Brian D Lehmann, David M Terrian, et al.Journal of Magnetic Resonance Imaging : JMRI|August 1, 2006
Distribution of microstructural damage in the brains of professional boxers: a diffusion MRI studyMichael H Chappell, Aziz M Uluğ, Lijuan Zhang, et al.Computer Methods in Biomechanics and Biomedical Engineering|October 26, 2013
Objective classification of scapular kinematics in participants with movement faults of the scapula on clinical assessmentMartin B Warner, Gemma Whatling, Peter R Worsley, et al.Cell Cycle (Georgetown, Tex.)|January 11, 2014
Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cellsMelissa Sokolosky, William H Chappell, Kristin Stadelman, et al.Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|December 23, 2008
Shoulder and elbow muscle activity during fully supported trajectory tracking in neurologically intact older peopleA M Hughes, C T Freeman, J H Burridge, et al.Disability and Rehabilitation. Assistive Technology|August 12, 2010
Stroke participants' perceptions of robotic and electrical stimulation therapy: a new approachAnn-Marie Hughes, Jane Burridge, Chris T Freeman, et al.Leukemia|April 28, 2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cellsF E Bertrand, L S Steelman, W H Chappell, et al.Cell Cycle (Georgetown, Tex.)|July 3, 2008
Targeting prostate cancer based on signal transduction and cell cycle pathwaysJohn T Lee, Brian D Lehmann, David M Terrian, et al.Advances in Enzyme Regulation|November 2, 2010
Targeting the cancer initiating cell: the Achilles' heel of cancerJames A McCubrey, William H Chappell, Stephen L Abrams, et al.Expert Opinion on Therapeutic Targets|August 13, 2008
Akt as a therapeutic target in cancerLinda S Steelman, Kristin M Stadelman, William H Chappell, et al.Pageof 13